V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20023702 | 20010069 | 1.62 | 72.7 | Disease modification (D) | 2013-07-22 | 2013-08-04 | FEC + DOCETAXEL | 02 | null | 20083745 | FEC + DOCETAXEL |
| 20023703 | 20010070 | 1.69 | 72.8 | Adjuvant (A) | 2017-07-30 | 2017-08-07 | FEC + DOCETAXEL | 02 | null | 20083762 | FEC + DOCETAXEL |
| 20023704 | 20070790 | 1.66 | null | Neo-adjuvant (N) | 2013-12-09 | 2014-01-07 | FEC + DOCETAXEL | N | N | 20083770 | FEC + DOCETAXEL |
| 20023705 | 20070790 | 1.58 | 67 | Adjuvant (A) | 2014-12-22 | 2015-01-08 | FEC 100 + DOCETAXEL | N | N | 20083770 | FEC + DOCETAXEL |
| 20023706 | 20070790 | 1.62 | 62 | Adjuvant (A) | 2014-10-03 | 2014-10-03 | FEC 100 + DOCETAXEL | N | N | 20083770 | FEC + DOCETAXEL |
| 20023707 | 20070790 | 1.63 | 102.9 | Neo-adjuvant (N) | 2014-11-16 | 2014-11-27 | FEC 100 + DOCETAXEL | 2 | N | 20083770 | FEC + DOCETAXEL |
| 20023708 | 20070790 | 1.63 | 64 | Neo-adjuvant (N) | 2016-07-12 | 2016-09-19 | FEC + DOCETAXEL | N | N | 20083770 | FEC + DOCETAXEL |
| 20023709 | 20010071 | null | null | Adjuvant (A) | 2015-09-22 | 2015-10-03 | FEC + DOCETAXEL | N | null | 20083787 | FEC + DOCETAXEL |
| 20023710 | 20010071 | 1.48 | null | Adjuvant (A) | null | 2016-06-01 | FEC + DOCETAXEL | null | null | 20083787 | FEC + DOCETAXEL |
| 20023711 | 20010072 | 1.59 | 73.6 | null | 2013-04-12 | 2013-04-27 | FEC + DOCETAXEL | N | N | 20083797 | FEC + DOCETAXEL |
| 20023712 | 20010072 | 1.62 | 79 | Adjuvant (A) | 2015-05-30 | 2015-06-07 | FEC 100 + DOCETAXEL | 02 | Y | 20083797 | FEC + DOCETAXEL |
| 20023713 | 20010072 | null | 70.15 | null | 2014-09-20 | 2014-10-10 | FEC + DOCETAXEL | N | N | 20083797 | FEC + DOCETAXEL |
| 20023714 | 20010073 | 1.73 | 60.8 | Adjuvant (A) | 2016-04-12 | 2016-04-30 | FEC 100 + DOCETAXEL | 02 | Y | 20083815 | FEC + DOCETAXEL |
| 20023715 | 20010074 | 1.61 | null | Neo-adjuvant (N) | 2016-04-21 | 2016-05-11 | FEC 100 + DOCETAXEL | N | N | 20083816 | FEC + DOCETAXEL |
| 20023716 | 20010074 | 1.74 | 69 | Neo-adjuvant (N) | 2015-11-09 | 2015-11-19 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20083816 | FEC + DOCETAXEL |
| 20023717 | 20010074 | 1.59 | 173 | Not known (9) | 2017-01-30 | 2017-02-04 | FEC + DOCETAXEL | N | null | 20083816 | FEC + DOCETAXEL |
| 20023718 | 20010074 | 1.61 | 57.9 | Neo-adjuvant (N) | 2016-10-06 | 2016-10-08 | FEC 100 + DOCETAXEL | 2 | N | 20083816 | FEC + DOCETAXEL |
| 20023719 | 20010075 | 1.59 | 68 | Adjuvant (A) | 2016-11-14 | 2016-12-01 | FEC 100 + DOCETAXEL | 2 | N | 20083836 | FEC + DOCETAXEL |
| 20023720 | 20010075 | 1.74 | 69.7 | Adjuvant (A) | null | 2017-11-01 | FEC 100 + DOCETAXEL | N | N | 20083836 | FEC + DOCETAXEL |
| 20023721 | 20010075 | 1.65 | 65.8 | Adjuvant (A) | 2014-06-06 | 2014-06-21 | FEC + DOCETAXEL | N | N | 20083836 | FEC + DOCETAXEL |
| 20023722 | 20010075 | null | 90.2 | Adjuvant (A) | 2016-10-22 | 2016-10-31 | FEC + DOCETAXEL | N | null | 20083836 | FEC + DOCETAXEL |
| 20023723 | 20010076 | null | 84.95 | Adjuvant (A) | null | 2015-09-09 | FEC + DOCETAXEL | null | N | 20083850 | FEC + DOCETAXEL |
| 20023724 | 20010077 | 1.6 | 70.25 | null | 2014-07-16 | 2014-07-18 | FEC 100 + DOCETAXEL | 1 | N | 20083856 | FEC + DOCETAXEL |
| 20023725 | 20010077 | 1.58 | 89.4 | Neo-adjuvant (N) | 2015-10-13 | 2015-10-26 | FEC 100 + DOCETAXEL | 02 | Y | 20083856 | FEC + DOCETAXEL |
| 20023726 | 20010077 | null | 71.5 | null | 2017-05-22 | 2017-05-22 | FEC 100 + DOCETAXEL | null | null | 20083856 | FEC + DOCETAXEL |
| 20023727 | 20010078 | null | null | Adjuvant (A) | 2016-07-14 | 2016-08-09 | FEC 100 + DOCETAXEL | 2 | N | 20083859 | FEC + DOCETAXEL |
| 20023728 | 20010078 | 1.56 | 63 | Adjuvant (A) | 2013-07-24 | 2013-08-05 | FEC + DOCETAXEL | 02 | N | 20083859 | FEC + DOCETAXEL |
| 20023729 | 20010079 | 1.58 | 66.4 | Neo-adjuvant (N) | 2015-06-16 | 2015-06-17 | FEC + DOCETAXEL | N | null | 20083866 | FEC + DOCETAXEL |
| 20023730 | 20010079 | 1.62 | 66 | Adjuvant (A) | 2016-09-03 | 2016-09-16 | FEC + DOCETAXEL | N | N | 20083866 | FEC + DOCETAXEL |
| 20023731 | 20010079 | null | 80 | Adjuvant (A) | 2014-05-25 | 2014-06-24 | FEC 100 + DOCETAXEL | N | N | 20083866 | FEC + DOCETAXEL |
| 20023732 | 20010080 | null | null | Neo-adjuvant (N) | 2017-10-18 | 2017-10-18 | FEC 100 + DOCETAXEL | 2 | N | 20083876 | FEC + DOCETAXEL |
| 20023733 | 20010081 | 1.7 | 97.8 | Adjuvant (A) | 2014-12-12 | 2014-12-28 | FEC + DOCETAXEL | N | N | 20083878 | FEC + DOCETAXEL |
| 20023734 | 20010081 | 1.68 | 100 | Adjuvant (A) | null | 2015-10-25 | FEC + DOCETAXEL | N | N | 20083878 | FEC + DOCETAXEL |
| 20023735 | 20010082 | 1.6 | 61 | Not known (9) | 2017-01-26 | 2017-02-02 | FEC + DOCETAXEL | 02 | N | 20083881 | FEC + DOCETAXEL |
| 20023736 | 20010082 | 1.62 | 50 | Neo-adjuvant (N) | 2014-08-15 | 2014-08-27 | FEC + DOCETAXEL | 2 | null | 20083881 | FEC + DOCETAXEL |
| 20023737 | 20010082 | 1.66 | 65.1 | Not known (9) | 2015-08-15 | 2015-09-04 | FEC 100 + DOCETAXEL | 02 | N | 20083881 | FEC + DOCETAXEL |
| 20023738 | 20010083 | null | 63.7 | Adjuvant (A) | 2014-12-20 | 2014-12-30 | FEC + DOCETAXEL | N | null | 20083891 | FEC + DOCETAXEL |
| 20023740 | 20108373 | 1.68 | 57 | Neo-adjuvant (N) | 2016-12-30 | 2017-01-12 | FEC + DOCETAXEL | 02 | N | 20083897 | FEC + DOCETAXEL |
| 20023741 | 20010084 | 1.59 | 86.8 | Neo-adjuvant (N) | 2015-10-21 | 2015-10-21 | FEC + DOCETAXEL | 02 | N | 20083905 | FEC + DOCETAXEL |
| 20023742 | 20010084 | 1.64 | 75.4 | Adjuvant (A) | 2016-10-28 | 2016-11-04 | FEC 100 + DOCETAXEL | N | N | 20083905 | FEC + DOCETAXEL |
| 20023743 | 20010084 | 1.71 | 63.4 | Adjuvant (A) | 2014-01-28 | 2014-01-28 | FEC + DOCETAXEL | 2 | Y | 20083905 | FEC + DOCETAXEL |
| 20023744 | 20010085 | 1.65 | 86.2 | Adjuvant (A) | 2015-06-22 | 2015-06-26 | FEC + DOCETAXEL | 02 | N | 20083914 | FEC + DOCETAXEL |
| 20023745 | 20010085 | 1.76 | 61.9 | Adjuvant (A) | null | 2013-08-31 | FEC + DOCETAXEL | N | N | 20083914 | FEC + DOCETAXEL |
| 20023746 | 20010086 | 1.64 | 91.6 | Adjuvant (A) | 2013-05-13 | 2013-06-03 | FEC + DOCETAXEL | 01 | N | 20083921 | FEC + DOCETAXEL |
| 20023747 | 20010087 | 0.79 | 76.5 | null | 2013-08-07 | 2013-08-17 | FEC 100 + DOCETAXEL | N | null | 20083922 | FEC + DOCETAXEL |
| 20023748 | 20010087 | 1.61 | 86.5 | Neo-adjuvant (N) | 2015-01-07 | 2015-01-07 | FEC + DOCETAXEL | 02 | N | 20083922 | FEC + DOCETAXEL |
| 20023749 | 20010088 | null | null | Adjuvant (A) | null | 2017-10-12 | FEC + DOCETAXEL | null | null | 20083925 | FEC + DOCETAXEL |
| 20023750 | 20010089 | 1.66 | 76.9 | Adjuvant (A) | 2013-09-12 | 2013-09-25 | FEC 100 + DOCETAXEL | N | N | 20083927 | FEC + DOCETAXEL |
| 20023751 | 20010090 | 1.73 | 82 | Adjuvant (A) | null | 2016-04-14 | FEC + DOCETAXEL | N | N | 20083928 | FEC + DOCETAXEL |
| 20023752 | 20010091 | 1.7 | 104 | Curative (C) | 2014-08-15 | 2014-08-22 | FEC + DOCETAXEL | N | N | 20083929 | FEC + DOCETAXEL |